Related Experiment Video
Updated: Mar 6, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Role of microRNAs in endocrine cancer metastasis
Cilene Rebouças Lima1, Cibele Crastequini Gomes1, Marinilce Fagundes Santos1
1Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, Prédio I, CEP 05508-000, São Paulo, SP, Brazil.
Abstract:
The deregulation of transcription and processing of microRNAs (miRNAs), as well as their function, has been involved in the pathogenesis of several human diseases, including cancer. Despite advances in therapeutic approaches, cancer still represents one of the major health problems worldwide. Cancer metastasis is an aggravating factor in tumor progression, related to increased treatment complexity and a worse prognosis. After more than one decade of extensive studies of miRNAs, the fundamental role of these molecules in cancer progression and metastasis is beginning to be elucidated. Recent evidences have demonstrated a significant role of miRNAs on the metastatic cascade, acting either as pro-metastatic or anti-metastatic. They are involved in distinct steps of metastasis including epithelial-to-mesenchymal transition, migration/invasion, anoikis survival, and distant organ colonization. Studies on the roles of miRNAs in cancer have focused mainly on two fronts: the establishment of a miRNA signature for different tumors, which may aid in early diagnosis using these miRNAs as markers, and functional studies of specific miRNAs, determining their targets, function and regulation. Functional miRNA studies on endocrine cancers are still scarce and represent an important area of research, since some tumors, although not frequent, present a high mortality rate. Among the endocrine tumors, thyroid cancer is the most common and best studied. Several miRNAs show lowered expression in endocrine cancers (i.e. miR-200s, miR-126, miR-7, miR-29a, miR-30a, miR-137, miR-206, miR-101, miR-613, miR-539, miR-205, miR-9, miR-195), while others are commonly overexpressed (i.e. miR-21, miR-183, miR-31, miR-let7b, miR-584, miR-146b, miR-221, miR-222, miR-25, miR-595). Additionally, some miRNAs were found in serum exosomes (miR-151, miR-145, miR-31), potentially serving as diagnostic tools. In this review, we summarize studies concerning the discovery and functions of miRNAs and their regulatory roles in endocrine cancer metastasis, which may contribute for the finding of novel therapeutic targets. The review focus on miRNAs with at least some identified targets, with established functions and, if possible, upstream regulation.
Insights
MicroRNAs (miRNAs) play a crucial role in cancer metastasis, acting as either pro-metastatic or anti-metastatic factors. Understanding these microRNAs and their functions offers potential for novel therapeutic targets in endocrine cancers.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) deregulation is implicated in human diseases, including cancer.
- Cancer metastasis significantly complicates treatment and worsens prognosis.
- The role of miRNAs in cancer progression and metastasis is increasingly recognized.
Purpose of the Study:
- To review the discovery and functions of miRNAs in endocrine cancer metastasis.
- To highlight the regulatory roles of miRNAs in the metastatic cascade.
- To identify potential novel therapeutic targets based on miRNA functions.
Main Methods:
- Literature review of studies on miRNAs in endocrine cancer metastasis.
- Focus on miRNAs with identified targets and established functions.
- Analysis of upstream regulation of key miRNAs.
Main Results:
- miRNAs are involved in distinct metastatic steps like EMT, migration, invasion, and colonization.
- Specific miRNAs are underexpressed (e.g., miR-200s, miR-126) or overexpressed (e.g., miR-21, miR-183) in endocrine cancers.
- Some miRNAs in serum exosomes show potential as diagnostic tools.
Conclusions:
- miRNAs are critical regulators of endocrine cancer metastasis.
- Further research into functional miRNA studies is essential for endocrine cancers.
- Targeting specific miRNAs may offer novel therapeutic strategies for cancer treatment.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Mitogens and the Cell Cycle

